Horizon Therapeutics plc to Participate in the JMP Securities Life Sciences Conference

Horizon Therapeutics plc to Participate in the JMP Securities Life Sciences Conference

06/04/19

DUBLIN--(BUSINESS WIRE)--Jun. 4, 2019-- Horizon Therapeutics plc (Nasdaq: HZNP), today announced that the company will participate in the following conference in June:

The JMP Securities Life Sciences Conference

  • Date: June 20, 2019
  • Presentation Time: 10 a.m. ET
  • Location: New York

The conference presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcast will be available for the event.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

Source: Horizon Therapeutics plc

Investors:
Tina Ventura
Senior Vice President,
Investor Relations
investor-relations@horizontherapeutics.com

Ruth Venning
Executive Director,
Investor Relations
investor-relations@horizontherapeutics.com

U.S. Media:
Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer
media@horizontherapeutics.com

Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie